13/07/2001

MediVision announces the issuance of 60,338 new shares to a group of Dutch investors

Yokneam Elite, Israel, June 19, 2001. MediVision Medical Imaging Ltd. (EURO.NM:MEDV) (the "company") announced today the approval of the Banking and Finance Commission regarding the Consummation of a private placement of 60,338 new shares at a per-share price of 3.09EUR to a group of Dutch investors.

The company has placed a demand for listing of those shares at the Euronext stock exchange, and as mentioned above, the approval of the Banking and Financial Commission was granted.

The annual financial statement is available from MediVision or at Delta Lloyd Securities, Tel.: +32 3 204 77 46

MediVision, an Israeli-based company, designs, manufactures and markets digital imaging devices for ophthalmic applications with an emphasis on diagnostic procedures related to the retina.